AGAH RAMTIN (Chief Medical Officer) purchased 632.7% of their position (40.98K shares) of RENOVORX, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 1 purchase
Filed: 1/30/2024ACC: 0001493152-24-004372
DirectorOfficer10% Owner· Chief Medical Officer
Since Aug 2021
+81.97K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
81.97K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40.98K
Price / share
—
Trade value
—
% of position
632.7%
1/26/2024
6.48K→47.46K
Total
Net shares
+40.98K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/26/2024 | P · Purchase | +40.98K | — | — | 632.7% | 6.48K | 47.46K |
| Total | +40.98K | $0.00 | ||||||
Derivative Transactions1
Warrants
Direct
Converts to
Common Stock
40.98K shares
Shares
+40.98K
Strike price
1.22
Held after
40.98K
Exercisable
—
1/26/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Direct | Common Stock40.98K shares | 1/26/2024 | P · Purchase | +40.98K | 1.22 | — | 40.98K |